Does GALSULFASE Cause Poor venous access? 19 Reports in FDA Database

Q: Does GALSULFASE cause Poor venous access?

19 reports of Poor venous access have been filed with the FDA for GALSULFASE, representing 0.7% of all GALSULFASE adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Poor venous access have been filed in association with GALSULFASE (NAGLAZYME). This represents 0.7% of all adverse event reports for GALSULFASE.

Reports of Poor venous access with GALSULFASE

0.7%

of all GALSULFASE reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From GALSULFASE?

Of the 19 reports, 5 (26.3%) required hospitalization.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GALSULFASE. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does GALSULFASE Cause?

Pyrexia (338) Pneumonia (197) Cough (181) Dyspnoea (154) Spinal cord compression (108) Vomiting (106) Oxygen saturation decreased (100) Fatigue (92) Pain (81) Headache (75)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which GALSULFASE Alternatives Have Lower Poor venous access Risk?

GALSULFASE vs GAMMAGARD LIQUID GALSULFASE vs GANAXOLONE GALSULFASE vs GANCICLOVIR GALSULFASE vs GANIRELIX GALSULFASE vs GATIFLOXACIN

GALSULFASE Full Profile All Poor venous access Reports All Drugs Causing Poor venous access GALSULFASE Demographics